Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide versus strontium ranelate histomorphometric study in postmenopausal osteoporosis
2005-000515-95Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of teriparatide and strontium ranelate in osteoporosis (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Mineralization surface. Started Jun 2005; status: completed.
02
Drugs
teriparatidestrontium ranelate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-000515-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000515-95.